濮阳东方医院妇科做人流手术技术(濮阳东方医院妇科做人流收费很低) (今日更新中)

The U.S. Olympic Committee has announced Salt Lake City will be its choice in a bid for the Winter Games in 2030 or beyond."We won!" Governor Gary Herbert cheered, holding hands in victory with Salt Lake City Mayor Jackie Biskupski, Council Chairwoman Erin Mendenhall and others."This has been the culmination of a significant team effort, starting with the support of the public," the governor added.The announcement came following a meeting by the U.S. Olympic Committee in San Francisco on Friday. Salt Lake City was competing with Denver for the nomination.The International Olympic Committee is expected to pick the next host cities for future Games in 2023.Salt Lake City has argued it is uniquely situated to host another Olympics. Our venues are still operating and in excellent condition and our infrastructure is in place with billions in expansions (light rail, a new airport, etc.). There is also significant support with polls showing 89% of Utahns in favor of another bid."We feel like we’re as prepared as we could be. We have unanimity with our public officials that have lined up behind this effort," said Jeff Robbins, the president of the Utah Sports Commission.The cost to host an Olympics would also be cheaper than other cities. It would cost about .4 billion, but boosters insist it would not cost any state or local tax dollars. Instead, it would be paid for in broadcast rights, sponsorships and ticket sales."People say, 'Well, is this worth the investment?' The investment is zero! Look at all we get. Number one, we get the spotlight of the world on Utah and we get to show the world what a great state this is, what great people are here. The volunteers were fantastic last time," said Fraser Bullock, an executive for Salt Lake's 2002 Winter Olympics and the co-chair of this Olympic Exploratory Committee.Utah estimates it received more than billion in economic benefit from the 2002 Winter Olympics. Mayor Biskupski said she envisioned the next Games that Utah could host would be even better. She said there would be an emphasis on sustainability (as in, environmentally friendly) and a modern Olympics."This will be an entirely new Games and experience. We're excited to bring that vision," she said. 2247

The U.S. government’s auto safety agency is investigating complaints that headlights can suddenly fail in some older Kia SUVs. The National Highway Traffic Safety Administration says the probe covers about 392,000 Kia Sorento SUVs from the 2011 through 2013 model years. The agency says it has 74 reports of failures that may be related to connectors overheating. There were no reports of crashes or injuries. Some complaints allege that both headlights went out in the middle of turns or while traveling on the highway. In a statement, Kia says its cooperating, and its own investigation shows that both headlights have not gone dark at the same time. U.S. investigators will determine how often the problem happens and look into the safety consequences. 763

The Supreme Court on Tuesday rejected a challenge to a controversial Arkansas abortion law blocking medication-induced abortions.The law, passed in 2015, says that any physician who "gives, sells, dispenses, administers, or otherwise provides or proscribes the abortion-inducing drug" shall have to have a contract with a physician who has admitting privileges at a nearby hospital.The order, issued without comment, clears the way for the law to go into effect in mid-July if no other legal action is taken. Planned Parenthood is expected to make another challenge to the law in US district court."The Arkansas restriction, which was enacted supposedly to protect women's health, is medically unnecessary," lawyers for Planned Parenthood argued in court papers. They say it is unconstitutional because it places an undue burden on a patient's right to choose abortion.Medication abortion — available only early in a pregnancy — involves the combination of two pills called mifepristone and misoprostol.Lawyers for Arkansas say the law is a "commonsense requirement" that "merely requires medication abortion providers to have a contractual relationship (to ensure follow-up treatment if needed) with a physician that has admitting privileges.The-CNN-Wire 1263

The Sinaloa drug cartel, once run by one of the most wanted men in the world, El Chapo, has made its way to Northeast Ohio. It's a drug-trafficking ring moving large amounts of drugs from Mexico onto the streets."I don't think people understand how significant and embedded it is in Northeast Ohio," said Keith Martin, Assistant Special Agent in Charge of Cleveland's Drug Enforcement Administration. Authorities recently found a stash house in a Maple Heights neighborhood and another on Cleveland's west side. "The unfortunate fact is the drugs on our streets come from somewhere. Coco plants don't grow in Cleveland. Poppy plants don't grow in Parma, they come from somewhere else. They are, increasingly, in almost every case, the drugs are coming from Mexican cartels," said Justin Herdman, U.S. Attorney for the Northern District of Ohio. A three-year long DEA investigation, dubbed "Operation Loaded Deck," focused on taking down the local arm of the notorious Sinaloa cartel. During the investigation, authorities seized large quantities of heroin, cocaine and fentanyl, some of which were concealed in hidden compartments in cars. The drugs were moved across the U.S.-Mexican border and transported in these cars outfitted with secret traps. "Often times they'll go to great lengths, whether they've constructed a trap in a vehicle or a natural void in the vehicle," Major Gene Smith with the Ohio State Highway Patrol said.Just as astonishing, Cartel members were hiding in plain sight the whole time, even taking in a Cavaliers game — courtside."These aren't street-level dealers, they were dealing in massive quantities and, in return, huge amounts of cash," Herdman said. By the end of the investigation, 29 kilos of cocaine, eight kilos of heroin, a kilo of fentanyl and four pounds of marijuana were seized, along with nearly 0,000, guns, vehicles and dozens of cell phones. Operation Loaded Deck ended with 19 people sent to federal prison for their roles in the drug trafficking organization. 2115

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261

来源：资阳报